FLUORINE-CONTAINING 5-[2-(PYRID-3-YL)-ETHYL]-2,3,4-TETRAHYDRO-1H-PYRIDO[4,3-B]INDOLES AS AGENTS FOR REDUCING UNCONTROLLED PROTEIN AGGREGATION

The claimed fluorine-containing substituted 5-[2-(pyrid-3-yl)-ethyl]-2,3,4-tetrahydro-1H-pyrido[4,3-b]indoles and hydrochlorides and hydrobromides thereof, which have the general formula (I), as agents for reducing uncontrolled protein aggregation in the nervous system, the pharmacological agent bas...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SOKOLOV, VLADIMIR BORISOVICH, AKSINENKO, ALEKSEY YURYEVICH, NINKINA, NATALYA NIKOLAEVNA, SHELKOVNIKOVA, TATYANA ALEKSANDROVNA, BOLKUNOV, ALEKSEY VIKTOROVICH, BACHURIN, SERGEY OLEGOVICH, USTUGOV, ALEKSEY ANATOLYEVICH
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The claimed fluorine-containing substituted 5-[2-(pyrid-3-yl)-ethyl]-2,3,4-tetrahydro-1H-pyrido[4,3-b]indoles and hydrochlorides and hydrobromides thereof, which have the general formula (I), as agents for reducing uncontrolled protein aggregation in the nervous system, the pharmacological agent based thereon and the method for using same relate to the field of medicine and solve the problem of increasing the range of agents for combating the development of destructive processes in the central and peripheral nervous system. where R 1 = R 2 = R 4 = H, Me; or R 4 + R 2 = -CH 2 -CH 2 -; R 3 = H, (C 1 -C 6 )alkyl, (C 2 -C 6 )alkenyl, (C 3 -C 6 )alkynyl, (C 1 -C 6 )alkoxy (C 1 -C 6 )alkyl, [F, Cl, Br, NO 2 , (C 1 -C 6 )alkyl, (C 1 -C 6 ) alkoxy, acyl, (C 1 -C 6 )alkylsulfonyl, (C 1 -C 6 )alkoxycarbonyl - substituted] aryloxy (C 1 -C 6 )alkyl, (C 3 -C 7 )cycloalkyl, [F, Cl, Br, NO 2 , (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, acyl, (C 1 -C 6 ) alkylsulfonyl, (C 1 -C 6 )alkoxycarbonyl - substituted] aryl, heteryl, (C 1 -C 6 )alkylsulfonyl, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 ) acyl, [F, Cl, Br, NO 2 , (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, acyl, (C 1 -C 6 )alkylsulfonyl, (C 1 -C 6 )alkoxycarbonyl - substituted] aroyl, heteroyl, N,N-dialkylcarbamoyl, N,N-dialkylaminosulfonyl; R 5 , R 6 , R 7 , R 8 = H, F, Cl, Br, CN, OH, CF 3 , CF 3 O, CHF 2 O, NO 2 , (C 1 -C 6 )alkyl, (C 3 -C 7 )cycloalkyl, (C 1 -C 6 )alkoxy, [F, Cl, Br, NO 2 , (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, acyl, (C 1 -C 6 )alkylsulfonyl, (C 1 -C 6 ) alkoxycarbonyl - substituted] aryl, [F, Cl, Br, NO 2 , (C 1 -C 6 ) alkyl, (C 1 -C 6 )alkoxy, acyl, (C 1 -C 6 )alkylsulfonyl, (C 1 -C 6 ) alkoxycarbonyl - substituted] aryloxy, (Me, Cl, Br - substituted) pyridyl, (C 1 -C 6 )alkylsulfonyl, (C 1 -C 6 ) alkoxycarbonyl, (C 1 -C 6 )acyl, [F, Cl, Br, NO 2 , (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, acyl, (C 1 -C 6 )alkylsulfonyl, (C 1 -C 6 )alkoxycarbonyl - substituted] aroyl, N,N-dialkylcarbamoyl, N,N-dialkylaminosulfonyl; R 9 = F, 2F, CHF 2 , CC1F 2 , CF 3 .; X = nothing, Cl. Br.